TA
Takeda
TAK · NYSE
$18.37 -0.46% (-$0.08)
1M +5.13%
Market Cap ¥9.04T
P/E Ratio 49.65x
Div. Yield 1.74%
ROE 2.42%
Bulios Fair Price
$25.66
39.7% upside
Trenutna cena
$18.37
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TAK trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
66 /100
Fair PEG 0.50x
P/E 49.65x
P/B 1.20x
Growth
48 /100
Stable FCF growth 33.04%
EPS growth 14.14%
Book val. growth 7.11%
Profitability
63 /100
Moderate Op. margin 10.99%
Gross margin 59.01%
FCF margin 12.02%
Quality
13 /100
Poor ROA 1.16%
ROIC 2.54%
Asset turnover 0.30x
Debt
45 /100
Moderate Int. coverage 1.86x
Debt/Equity 0.65x
Net debt/EBITDA 3.53x
Stability
46 /100
Moderate EPS volatility 76.77%
Beta 0.09x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TAK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Julie So-Young Kim
Employees
47,029
Headquarters
Tokyo
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report